| Literature DB >> 35732737 |
Lucia Luengo-Gutierrez1, Jessica S Chadwick1, Elisabeth Serger1,2, Guiping Kong1, Luming Zhou1, Greg Crawford3, Matt C Danzi4, Antonis Myridakis5, Alexander Brandis6, Adesola Temitope Bello7, Franziska Müller1, Alexandros Sanchez-Vassopoulos1, Francesco De Virgiliis1, Phoebe Liddell1, Marc Emmanuel Dumas8,9, Jessica Strid3, Sridhar Mani10, Dylan Dodd11,12, Simone Di Giovanni13.
Abstract
The regenerative potential of mammalian peripheral nervous system neurons after injury is critically limited by their slow axonal regenerative rate1. Regenerative ability is influenced by both injury-dependent and injury-independent mechanisms2. Among the latter, environmental factors such as exercise and environmental enrichment have been shown to affect signalling pathways that promote axonal regeneration3. Several of these pathways, including modifications in gene transcription and protein synthesis, mitochondrial metabolism and the release of neurotrophins, can be activated by intermittent fasting (IF)4,5. However, whether IF influences the axonal regenerative ability remains to be investigated. Here we show that IF promotes axonal regeneration after sciatic nerve crush in mice through an unexpected mechanism that relies on the gram-positive gut microbiome and an increase in the gut bacteria-derived metabolite indole-3-propionic acid (IPA) in the serum. IPA production by Clostridium sporogenes is required for efficient axonal regeneration, and delivery of IPA after sciatic injury significantly enhances axonal regeneration, accelerating the recovery of sensory function. Mechanistically, RNA sequencing analysis from sciatic dorsal root ganglia suggested a role for neutrophil chemotaxis in the IPA-dependent regenerative phenotype, which was confirmed by inhibition of neutrophil chemotaxis. Our results demonstrate the ability of a microbiome-derived metabolite, such as IPA, to facilitate regeneration and functional recovery of sensory axons through an immune-mediated mechanism.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35732737 DOI: 10.1038/s41586-022-04884-x
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 69.504